Skip to main content
Premium Trial:

Request an Annual Quote

AdvanDx Files with FDA for Clearance of Hospital Infection MDx Test

NEW YORK (GenomeWeb News) – AdvanDx has filed for 510(k) clearance from the US Food and Drug Administration for a molecular test that can detect an infectious yeast in blood cells. 
 
The company’s Yeast Traffic Light PNA FISH test detects up to five Candida yeast species from positive blood cultures in hours, rather days, AdvanDx said.
 
When it gets into the bloodstream, this yeast can cause Candidemia, which is frequently a hospital-acquired infection that affects over 24,000 US patients each year.
 
"The test will ultimately enable clinicians to provide more appropriate care, improve antifungal selection and hopefully improve outcomes for their patients," said AdvanDx CEO Thais Johansen in a statement.
 
The PNA FISH technology is an in situ hybridization assay that uses peptide nucleic acid probes to target species-specific ribosomal RNA in bacteria and yeast.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.